As an exercise, I found it worthwhile to map out the various options available or under development for the treatment of coronary artery disease. We assess the emphasis of current, near-term and future possible options for treatment in the color-coded scheme: Bold, black: Current, dominant treatment options Green: Near term options with potential to gain [...]
Coronary stents operate at a certain nexus of different therapeutic alternatives for the treatment of coronary artery disease. Given advances in materials technologies, biotech, drug-device hybrids, drug delivery and other fields, the therapeutic options available to the physician (interventional cardiologist or cardiac surgeon) for the treatment of coronary artery disease have proliferated. Any competitor marketing [...]
¶
Posted 12 April 2009
† P. Driscoll
§
cardiology § clinical practice § interventional cardiology § medtech § surgery
‡
°
Also tagged: bypass graft, CABG, cardiac surgery, coronary artery, drug eluting, drug-coated, MIDCAB, OPCAB, PTCA, revascularization, stent